These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29927498)

  • 21. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus ointment (Protopic) for atopic dermatitis.
    Pascual JC; Fleisher AB
    Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
    Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
    BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure.
    Kasai H; Kawasaki H; Fukushima-Nomura A; Yasuda-Sekiguchi F; Amagai M; Ebihara T; Tanese K
    Ann Med; 2021 Dec; 53(1):2205-2214. PubMed ID: 34797182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pimecrolimus: a review of its use in atopic dermatitis.
    Wellington K; Noble S
    Am J Clin Dermatol; 2004; 5(6):479-95. PubMed ID: 15663345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice.
    Noguchi A; Tominaga M; Takahashi N; Matsuda H; Kamata Y; Umehara Y; Ko KC; Suga Y; Ogawa H; Takamori K
    J Dermatol Sci; 2017 Apr; 86(1):54-62. PubMed ID: 28069324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
    Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis.
    Svensson A; Chambers C; Gånemo A; Mitchell SA
    Curr Med Res Opin; 2011 Jul; 27(7):1395-406. PubMed ID: 21563877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan.
    Nakagawa H
    Clin Drug Investig; 2006; 26(5):235-46. PubMed ID: 17163257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus-loaded chitosan-based nanoparticles as an efficient topical therapeutic for the effective treatment of atopic dermatitis symptoms.
    Lee JS; Oh E; Oh H; Kim S; Ok S; Sa J; Lee JH; Shin YC; Bae YS; Choi CY; Lee S; Kwon HK; Yang S; Choi WI
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):133005. PubMed ID: 38866268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The US FDA 'black box' warning for topical calcineurin inhibitors: an ongoing controversy.
    Ring J; Möhrenschlager M; Henkel V
    Drug Saf; 2008; 31(3):185-98. PubMed ID: 18302444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis.
    Paller AS; Fölster-Holst R; Chen SC; Diepgen TL; Elmets C; Margolis DJ; Pollock BH
    J Am Acad Dermatol; 2020 Aug; 83(2):375-381. PubMed ID: 32246968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials.
    Schmitt J; von Kobyletzki L; Svensson A; Apfelbacher C
    Br J Dermatol; 2011 Feb; 164(2):415-28. PubMed ID: 20819086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addressing treatment challenges in atopic dermatitis with novel topical therapies.
    Silverberg JI; Nelson DB; Yosipovitch G
    J Dermatolog Treat; 2016 Nov; 27(6):568-576. PubMed ID: 27165566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Munzenberger PJ; Montejo JM
    Pharmacotherapy; 2007 Jul; 27(7):1020-8. PubMed ID: 17594208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.